Clinical Trial Update: Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on prophylactic ranibizumab for exudative age-related macular degeneration across phase 1 and phase 2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Southern California Desert Retina Consultants, MC | Conditions: Age-related Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED